AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investors are so bullish that Palantir stock recently zoomed past $150 per share, giving it a market cap of nearly $350 ...

AI and PLTR are redefining enterprise AI with sharply different strategies. See how their visions for the future stack up.

Nvidia and Palantir are currently worth a collective $4.5 trillion, but Amazon can surpass that figure within five years, ...

ENHANS LOGO Selected for Palantir Startup Fellowship LAM-based 'Agentic AI Agents' Lead Commerce Innovation Selected Among 25 Global Companies for Startup Fellowship, Earning DevCon3 Demonstration ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

If you missed the boat on Palantir (NASDAQ:PLTR) stock’s incredibly multi-bagger surge over the past year and aren’t remotely ...

The administration’s long-awaited AI Action Plan gives Silicon Valley the green light.